Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritis

Author(s):
Smolen, J.S.; Boers, M.; Abadie, E.C.; Breedveld, F.C.; Emery, P.; Bardin, T.; Goel, N.; Ethgen, D.J.; Avouac, B.P.; Durez, P.; Flamion, B.; Laslop, A.; Miossec, P.; Reiter, S.; Reginster, J.Y.; Task Force Grp Respect Ethics & Ex
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-01-17
Language
English
Is part of
Rheumatology
hdl
1887/119343
doi
10.1093/rheumatology/keq413